IP Library Granted Patent US 9,476,812
Granted Patent B2
US 9,476,812 · App. 13/952,130 · Granted Oct 25, 2016

Methods for isolating a target analyte from a heterogeneous sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,476,812
App. No.
13/952,130
Granted
Oct 25, 2016
Kind
B2
Abstract

The invention generally relates to methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.

Claims (13)

1. A method for isolating pathogens from a heterogeneous sample, the method comprising

obtaining a heterogeneous sample comprising pathogens;

introducing the heterogeneous sample into a fluidic device through a vessel interface of the fluidic device;

introducing to the heterogeneous sample from a reagent storage chamber of the fluidic device a composition comprising at least one magnetic particle conjugated to at least two sets of capture moieties, wherein each set of capture moieties is specific for different pathogen,

incubating in the fluidic device the sample and the composition; and

identifying the different pathogens in the sample.

2. The method of claim 1 , wherein each set of capture moieties is present at a concentration designed for detection of a specific pathogen in said sample.

3. The method of claim 1 , wherein the at least two sets are provided at different concentrations.

4. The method of claim 1 , wherein the capture moieties are selected from the group consisting of antibodies, lectins, bacteriophages, antimicrobial agents, and oligonucleotides.

5. The method of claim 1 , further comprising lysing the pathogen to release nucleic acid.

6. The method of claim 5 , further comprising conducting an assay on the nucleic acid to identify the pathogen.

7. The method of claim 6 , wherein the assay is selected from the group consisting of a sequencing reaction and a polymerase chain reaction.

8. The method of claim 7 , wherein the assay is a multiplex assay.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 041154/0786 →
MERGER Recorded Jan 22, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 037558/0982 →
CHANGE OF NAME Recorded Dec 29, 2015
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 037372/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2014
From: DRYGA, SERGEY A.; ESCH, VICTOR; CLARIZIA, LISA-JO ANN; ADAMS, EDDIE W.; UNG, THEARITH H.; SITDIKOV, RAVIL A.
To: NANOMR INC.
Reel/Frame 032163/0863 →